ブックタイトル血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

概要

血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

189. Cookson ST, Ihrig M, O’Mara EM, et al. Increased bloodstream infection rates in surgical patientsassociated with variation from recommended use and care following implementation of a needleless device.Infect Control Hosp Epidemiol 1998; 19:23?7.190. Seymour VM, Dhallu TS, Moss HA, Tebbs SE, Elliot TS. A prospective clinical study to investigate themicrobial contamination of a needle-less connector. J Hosp Infect 2000; 45:165?8.191. Luebke MA, Arduino MJ, Duda DL, et al. Comparison of the microbial barrier properties of a needleless anda conventional needle-based intravenous access system. Am J Infect Control 1998; 26:437?41.192. McDonald LC, Banerjee SN, Jarvis WR. Line-associated bloodstream infections in pediatric intensive-careunitpatients associated with a needleless device and intermittent intravenous therapy. Infect Control HospEpidemiol 1998; 19:772?7.193. Mendelson MH, Short LJ, Schechter CB, et al. Study of a needleless intermittent intravenous-accesssystem for peripheral infusions: analysis of staff, patient, and institutional outcomes. Infect Control HospEpidemiol 1998; 19:401?6.194. Do AN, Ray BJ, Banerjee SN, et al. Bloodstream infection associated with needleless device use and theimportance of infection-control practices in the home health care setting. J Infect Dis 1999; 179:442?8.195. Soothill JS, Bravery K, Ho A, Macqueen S, Collins J, Lock P. A fall in bloodstream infections followed achange to 2% chlorhexidine in 70% isopropanol for catheter connection antisepsis: a pediatric single centerbefore/after study on a hemopoietic stem cell transplant ward. Am J Infect Control 2009; 37:626?30.196. Casey AL, Burnell S, Whinn H, Worthington T, Faroqui MH, Elliott TS. A prospective clinical trial to evaluatethe microbial barrier of a needleless connector. J Hosp Infect 2007; 65:212?8.197. Rupp ME, Sholtz LA, Jourdan DR, et al. Outbreak of bloodstream infection temporally associated with theuse of an intravascular needleless valve. Clin Infect Dis 2007; 44:1408?14.198. Salgado CD, Chinnes L, Paczesny TH, Cantey JR. Increased rate of catheter-related bloodstream infectionassociated with use of a needleless mechanical valve device at a long-term acute care hospital. InfectControl Hosp Epidemiol 2007; 28:684?8.199. Maragakis LL, Bradley KL, Song X, et al. Increased catheter-related bloodstream infection rates after theintroduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol 2006;27:67?70.200. Field K, McFarlane C, Cheng AC, et al. Incidence of catheter-related bloodstream infection among patientswith a needleless, mechanical valve-based intravenous connector in an Australian hematology-oncologyunit. Infect Control Hosp Epidemiol 2007; 28:610?3.201. Costello JM, Morrow DF, Graham DA, Potter-Bynoe G, Sandora TJ, Laussen PC. Systematic intervention toreduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit.Pediatrics 2008; 121:915?23.202. Frankel HL, Crede WB, Topal JE, Roumanis SA, Devlin MW, Foley AB. Use of corporate Six Sigmaperformance-improvement strategies to reduce incidence of catheter-related bloodstream infections in asurgical ICU. J Am Coll Surg 2005; 201:349?58.203. Galpern D, Guerrero A, Tu A, Fahoum B, Wise L. Effectiveness of a central line bundle campaign on lineassociatedinfections in the intensive care unit. Surgery 2008; 144:492?5; discussion 495.204. McKee C, Berkowitz I, Cosgrove SE, et al. Reduction of catheter-associated bloodstream infections inpediatric patients: experimentation and reality. Pediatr Crit Care Med 2008; 9:40?6.205. Pronovost PJ, Berenholtz SM, Goeschel CA. Improving the quality of measurement and evaluation inquality improvement efforts. Am J Med Qual 2008; 23:143?6.206. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infectionand criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309?32.59